Taken together, our molecular dynamics results suggest that OA has binding stability to core targets, especially PPARG, PPARA, and PTGS2, which have very high potential in OA anti-obesity. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.